FT
RVMD icon

Fiduciary Trust’s Revolution Medicines RVMD Stock Holding History

Fiduciary Trust’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.37M Buy
17,991
+93
+0.5% +$13.6K 0.04% 213
2026
Q1 		$1.74M Sell
17,898
-5,200
-23% -$525K 0.02% 305
2025
Q4 		$1.84M Buy
23,098
+3
+0% +$197 0.02% 295
2025
Q3 		$1.08M Hold
23,095
– – 0.01% 400
2025
Q2 		$850K Hold
23,095
– – 0.01% 432
2025
Q1 		$817K Hold
23,095
– – 0.01% 426
2024
Q4 		$1.01M Hold
23,095
– – 0.01% 354
2024
Q3 		$1.05M Hold
23,095
– – 0.01% 354
2024
Q2 		$896K Hold
23,095
– – 0.01% 358
2024
Q1 		$744K Hold
23,095
– – 0.01% 394
2023
Q4 		$662K Hold
23,095
– – 0.01% 398
2023
Q3 		$639K Hold
23,095
– – 0.01% 389
2023
Q2 		$618K Hold
23,095
– – 0.01% 407
2023
Q1 		$500K Buy
23,095
+4,629
+25% +$114K 0.01% 437
2022
Q4 		$440K Buy
18,466
+4,679
+34% +$99.5K 0.01% 474
2022
Q3 		$272K Buy
+13,787
New +$303K 0.01% 540
2022
Q2 		– Sell
-9,888
Closed -$252K – 664
2022
Q1 		$252K Hold
9,888
– – ﹤0.01% 593
2021
Q4 		$249K Hold
9,888
– – ﹤0.01% 599
2021
Q3 		$272K Hold
9,888
– – ﹤0.01% 580
2021
Q2 		$314K Hold
9,888
– – 0.01% 546
2021
Q1 		$454K Buy
+9,888
New +$443K 0.01% 471

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Fiduciary Trust's RVMD Position: Q2 2026 in Review

Fiduciary Trust increased its Revolution Medicines (RVMD) stake by 0.52% in Q2 2026, buying an estimated $13.6K and bringing the position to 17,991 shares worth $3.37M. The position accounts for 0.04% of the portfolio, ranked #213.

Fiduciary Trust first reported a position in RVMD in Q1 2021 and has held it in 21 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Fiduciary Trust held 17,991 shares of Revolution Medicines worth $3.37M as of Q2 2026.
  • Fiduciary Trust bought 93 Revolution Medicines shares in Q2 2026, an estimated $13.6K.
  • Revolution Medicines made up 0.04% of Fiduciary Trust's portfolio in Q2 2026, its #213 holding.
  • Fiduciary Trust first reported a position in Revolution Medicines in Q1 2021 and has held it in 21 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.